Latest News in the pharma Industry

All

Fujifilm increases production capacity and establishes new process development facilities

Fujifilm increases production capacity and establishes new process development facilities

19 Apr 2017

$130M USD investment to support growing market demand.

Read more 
Porvair acquires J.G. Finneran Associates

Porvair acquires J.G. Finneran Associates

19 Apr 2017

Finneran bringing glass, plastics and assembly manufacturing capabilities and strong US distribution.

Read more 
Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion

Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion

18 Apr 2017

Over the next two years Cobra will invest up to £15m (165m SEK) on a phased expansion plan, supporting the company’s R&D expertise in developing rapid and cost effective viral vector and DNA plasmid production platforms.

Read more 
Cardinal Health to acquire leading patient product portfolio from Medtronic for $6.1 billion

Cardinal Health to acquire leading patient product portfolio from Medtronic for $6.1 billion

18 Apr 2017

Increases Cardinal Health's product breadth in consumable medical products.

Read more 
Cobra Biologics embarks on £15 m gene therapy manufacturing operations expansion

Cobra Biologics embarks on £15 m gene therapy manufacturing operations expansion

18 Apr 2017

Capacity increase in response to customer demand for DNA and viral vector production.

Read more 
FDA approves Genentech’s Lucentis for diabetic retinopathy

FDA approves Genentech’s Lucentis for diabetic retinopathy

18 Apr 2017

First and only medicine FDA-approved to treat all forms of diabetic retinopathy.

Read more 
Allergan expands leading R&D NASH Program with Novartis Clinical Collaboration

Allergan expands leading R&D NASH Program with Novartis Clinical Collaboration

18 Apr 2017

Collaboration focused on Phase 2II clinical trial to evaluate use of Allergan's Cenicriviroc and Novartis' lead FXR agonist to treat NASH.

Read more 
FDA issues complete response letter for baricitinib

FDA issues complete response letter for baricitinib

16 Apr 2017

Additional clinical data are needed to determine the most appropriate doses.

Read more 
BMS to license anti-eTau and anti-myostatic compounds

BMS to license anti-eTau and anti-myostatic compounds

16 Apr 2017

Two separate agreements with Biogen and Roche.

Read more 
Scale Up in the pharmaceutical Industry

Scale Up in the pharmaceutical Industry

13 Apr 2017

In the present application from the pharmaceutical process development, the aim is to transfer processes from the 70ml reactor into the 25lt scale, as efficiently and reproducibly as possible. In most cases, such a scale-up step takes place in differen...

Read more 
Arch Biopartners' lead anti-bacterial drug candidate to enter investigator-sponsored Phase I human trial

Arch Biopartners' lead anti-bacterial drug candidate to enter investigator-sponsored Phase I human trial

13 Apr 2017

AB569, which consists of two active ingredients, sodium nitrite and EDTA, has a novel mechanism of action that differs from that of antibiotics.

Read more 
Bosch launches new WFI system at interpack

Bosch launches new WFI system at interpack

12 Apr 2017

Efficient alternative to distillation.

Read more